Survey Reveals Sjögren’s Syndrome Interferes With Daily Activities

Home / Health News / Survey Reveals Sjögren’s Syndrome Interferes With Daily Activities

Survey Reveals Sjögren’s Syndrome Disrupts Day To Day Activities

Nearly all women struggling with Sjögren’s syndrome are convinced that signs and symptoms hinder day to day activities, including work, household and leisure, based on a current survey. Sjögren’s syndrome, probably the most common autoimmune illnesses, attacks the moisture-producing glands and mainly causes severe dry eyes and xerostomia. It impacts as much as 4 million individuals the U . s . States, 90 % who are women.

When requested which signs and symptoms initially motivated sufferers to determine a physician for treatment, greater than 70 % of respondents indicated dry eyes (75 %) and xerostomia (72 percent). Laptop computer polled 3,190 people (94 percent women) from the Sjögren’s Syndrome Foundation.

Additionally, laptop computer uncovered the average time between your start of first signs and symptoms and diagnosis is 6.five years. The signs and symptoms of Sjögren’s can mimic other concerns, making diagnosis difficult.

Regrettably, there’s nobody test to identify Sjögren’s syndrome. When Sjögren’s syndrome is suspected, a number of tests is run, which aims to look for the amount of mouth and eye dryness and measure antibody markers within the bloodstream.

Like several autoimmune illnesses, there’s no remedy for Sjögren’s syndrome. However, there are various treatments open to manage signs and symptoms. Artificial tears may be used to alleviate dry eyes, while eating sugar-free gum and consuming water can offer temporary respite from xerostomia signs and symptoms. Additionally, an Food and drug administration-approved product known as EVOXAC® (cevimeline HCl) has additionally been highly effective for the xerostomia signs and symptoms of Sjögren’s syndrome.

Safety Factors

The most typical negative effects are sweating, headache, nausea, sinus problems, upper respiratory system infections, rhinitis and diarrhea.

You shouldn’t take EVOXAC® for those who have out of control bronchial asthma, eye inflammation, narrow position (position closure) glaucoma or allergic reactions to EVOXAC®.

Before you take EVOXAC®, inform your physician for those who have heart problems, controlled bronchial asthma, chronic bronchitis, emphysema, past kidney disease or gallstones or you take any heart medications, especially “beta-blockers.” For those who have these conditions, your physician will monitor you under close medical supervision when you are taking EVOXAC®.

Inform your physician and pharmacist if you’re taking prescription or higher-the-counter medications to prevent any possible drug interactions.

The security and effectiveness of EVOXAC® in patients under 18 years old haven’t been established.

Additional care ought to be taken if you’re seniors.

You ought to be careful when driving during the night or performing hazardous activities in reduced lighting while taking EVOXAC®.

Should you sweat excessively while taking EVOXAC®, you might become dehydrated. To avoid this, drink extra water and speak to your physician.

Please visit the individual Information sheet and speak to your physician.

Sjögren’s syndrome, probably the most common autoimmune illnesses, attacks the moisture-producing glands.